The authors added that the adoption of this technology in hospitals has already improved the manner in which healthcare practitioners detect and monitor KRAS, BRAF, and EGFR mutations in patients with lung, colon, and breast cancer, respectively [14]. The gene discussed is KRAS; the disease is breast cancer.